1. A novel indeno[1, 2-b]pyridinone derivative, a DNA intercalative human topoisomerase IIα catalytic inhibitor, for caspase 3-independent anticancer activity. Issue 51 (12th June 2017) Authors: Jeon, K. H.; Park, C.; Kadayat, T. M.; Shrestha, A.; Lee, E. S.; Kwon, Y. Journal: Chemical communications Issue: Volume 53:Issue 51(2017) Page Start: 6864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A step to prevent fallen womb: retrospective study. (May 2015) Authors: Khadgi, B.; Acharaya, R.; Shrestha, A. Journal: Physiotherapy Issue: Volume 101(2016)Supplement 1 Page Start: e742 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Achieving an effective handover is the duty of every doctor – Is general surgical handover in a district general hospital compliant with the royal college of surgeons of england guidelines?. (November 2015) Authors: Robertson, A.; Shrestha, A. Journal: International journal of surgery Issue: Volume 23(2015)Supplement 1 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adenoid (Acantholytic) Squamous Cell Carcinoma of Mandibular Gingiva. (23rd July 2021) Authors: Raut, T.; Keshwar, S.; Jaisani, M. R.; Shrestha, A. Other Names: Darling Mark Academic Editor. Journal: Case reports in dentistry Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cervical cancer screening utilization, and associated factors, in Nepal: a systematic review and meta-analysis. (September 2022) Authors: Shrestha, A.D.; Andersen, J.G.; Gyawali, B.; Shrestha, A.; Shrestha, S.; Neupane, D.; Ghimire, S.; Campbell, C.; Kallestrup, P. Journal: Public health Issue: Volume 210(2022) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cluster randomised trial to evaluate the clinical benefits of decision support interventions for older women with operable breast cancer. (October 2020) Authors: Wyld, L.; Reed, M.; Collins, K.; Burton, M.; Lifford, K.; Edwards, A.; Ward, S.; Holmes, G.; Morgan, J.; Bradburn, M.; Walters, S.; Ring, A.; Martin, C.; Shrestha, A.; Nettleship, A.; Brown, M.; Richards, P.; Todd, A.; Harder, H.; Brain, K. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated non-squamous (NSQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs). (February 2017) Authors: Shrestha, A.; Penrod, J.R.; Reck, M.; Spigel, D.R.; Smiechowski, B.; Bognar, K.; Van Eijndhoven, E.; Makris, C.; Healey, D.; Hertel, N.; Korytowsky, B.; Cope, S.; Vanderpuye-Orgle, J. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated non-squamous (NSQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs). (February 2017) Authors: Shrestha, A.; Penrod, J.R.; Reck, M.; Spigel, D.R.; Smiechowski, B.; Bognar, K.; van Eijndhoven, E.; Makris, C.; Healey, D.; Hertel, N.; Korytowsky, B.; Cope, S.; Vanderpuye-Orgle, J. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs). (February 2017) Authors: Eberhardt, W.E.E.; Vanderpuye-Orgle, J.; Reck, M.; Waterhouse, D.; Smiechowski, B.; Bognar, K.; Van Eijndhoven, E.; Makris, C.; Blackwood-Chirchir, A.; Hertel, N.; Korytowsky, B.; Cope, S.; Penrod, J.R.; Shrestha, A. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs). (February 2017) Authors: Eberhardt, W.E.E.; Vanderpuye-Orgle, J.; Reck, M.; Waterhouse, D.; Smiechowski, B.; Bognar, K.; van Eijndhoven, E.; Makris, C.; Blackwood-Chirchir, A.; Hertel, N.; Korytowsky, B.; Cope, S.; Penrod, J.R.; Shrestha, A. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗